Phase I/Ib Multiple Ascending Dose Study in China
Clinical trial NCT03523390 · COMPLETED
Trial details
- NCT number
- NCT03523390
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-24
- Primary completion
- 2019-07-29
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.